Compare KURA & CLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KURA | CLB |
|---|---|---|
| Founded | 2014 | 1936 |
| Country | United States | United States |
| Employees | N/A | 3500 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 830.1M | 909.8M |
| IPO Year | N/A | 1995 |
| Metric | KURA | CLB |
|---|---|---|
| Price | $8.13 | $19.50 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 2 |
| Target Price | ★ $26.88 | $12.50 |
| AVG Volume (30 Days) | ★ 1.4M | 353.3K |
| Earning Date | 02-25-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 0.20% |
| EPS Growth | N/A | ★ 25.86 |
| EPS | N/A | ★ 0.68 |
| Revenue | $104,029,000.00 | ★ $517,501,999.00 |
| Revenue This Year | $88.72 | N/A |
| Revenue Next Year | $76.50 | $4.33 |
| P/E Ratio | ★ N/A | $28.74 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.41 | $9.72 |
| 52 Week High | $12.49 | $20.36 |
| Indicator | KURA | CLB |
|---|---|---|
| Relative Strength Index (RSI) | 35.20 | 58.65 |
| Support Level | $8.02 | $18.61 |
| Resistance Level | $9.18 | $19.96 |
| Average True Range (ATR) | 0.41 | 0.71 |
| MACD | -0.04 | -0.08 |
| Stochastic Oscillator | 13.48 | 45.99 |
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.